Chemokines: Molecular double agents  by Horuk, Richard & Peiper, Stephen C.
Dispatch 1581
Chemokines: Molecular double agents
Richard Horuk* and Stephen C. Peiper†
Chemokines are best known as signalling molecules
that attract leukocytes to sites of inflammation, but
recent results show they are also important regulators
of hematopoiesis during development.
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Chemokines are potent chemoattractants that provide
directional cues to summon leukocytes — in essence, a
molecular 911 emergency call. As the pro-inflammatory
functions of chemokines are independent of specific
humoral and cellular immunological mechanisms, this
system provides a direct, early response to a variety of
stimuli, including infectious agents. Sometimes, however,
these molecules can inappropriately target immune cells to
attack their own tissues and organs, leading to inflammation
and cellular destruction that can have drastic consequences
for the host. The receptors for chemokines have recently
gained notoriety with the discovery that they have been
exploited as cofactors for cell entry by human immunodefi-
ciency virus-1 (HIV-1). In a more physiological light, recent
studies have revealed important roles for chemokines and
their receptors in hematopoiesis during development.
Chemokines are being discovered with increasing rapidity,
and the chemokine family now numbers well over 30 pro-
teins [1]. They fall into two major subfamilies, distin-
guished structurally by the configuration of the two
characteristic cysteine residues near the amino terminus:
the a-chemokines, with configuration C-X-C, and the b-
chemokines, with configuration C-C. The a-chemokines
include interleukin-8 (IL-8), melanoma growth stimula-
tory activity (MGSA), neutrophil-activating peptide-2 and
platelet factor 4; the b-chemokines include RANTES,
macrophage inhibitory proteins (MIPs) 1a and 1b, and
monocyte chemoattractant protein-1 (MCP-1). Recently,
lymphotactin, a ‘chemokine’ with only one amino-
proximal cysteine residue has been described [2], but the
physiological role of this protein is obscure, and it remains
to be seen whether it is a founding member of a third
chemokine superfamily or just a molecular oddity.
Chemokines transduce their signals through cell-surface
receptors of the heptahelical receptor superfamily, which
couple to trimeric guanine-nucleotide-binding (G) proteins
[3]. An individual receptor may bind one or more
chemokines in the same subfamily [3]. Receptors that
bind to selected chemokines of both C-X-C and C-C sub-
families have been described — the Duffy receptor is an
example — but so far they are of undetermined function
[4]. The ligand-binding repertoires of different receptors
significantly overlap, as do the sets of chemokine recep-
tors expressed by different types of target cell.
The main approach that has been taken to investigate the
functions of chemokines and their receptors has been to
use targeted recombination to generate ‘knockout’ mice
with specifically inactivated genes, but until recently the
insights provided by such studies have been limited. Mice
homozygous for a mutation of the MGSA receptor CXCR2,
for example, show only subtle abnormalities [5]. Neither
mice (Don Cook, personal communication) nor humans
[6,7] lacking functional CCR5 — a b-chemokine receptor
specific for RANTES, MIP-1a and MIP-1b — show any
obvious deleterious phenotype, though the latter are resis-
tant to infection by macrophage-tropic strains of HIV-1
(recently reviewed in [8]; see also below). Homozygous
MIP-1a mutants do not show any obvious defects in their
normal physiology, but they do give abnormal responses to
viral infections [9].
The chemokine/chemokine-receptor knockout mice that
have been described did not show any obvious develop-
mental abnormality. It is, however, now clear that chemo-
kines have functions that extend beyond their roles in
leukocyte migration. Chemokines have been shown to have
growth regulatory properties. MGSA, for example, is an
autocrine growth factor for melanoma cells and can trans-
form immortalized melanocytes [10]; and the expression of
CXCR2 by maturing keratinocytes suggests that MGSA is
also a growth and maturation factor for epidermal cells [11].
MIP-1a has been suggested to be a negative regulator of
hematopoietic stem cells, but only recently has a chemo-
kine been shown to play a critical role in hematopoiesis.
Nagasawa et al. [12] made mice with a targeted mutation of
the gene for a novel C-X-C chemokine, known as stromal
derived factor (SDF-1), and the resulting phenotype
revealed a role for SDF-1 in embryonic and adult
hematopoiesis. SDF-1 supports the growth of a stromal
cell-dependent pre-B-cell clone in vitro and its gene maps
to chromosome 10, away from the clusters of genes for C-
X-C and C-C chemokines on chromosomes 4 and 17,
respectively [13,14]. Interestingly, human and mouse SDF-
1 differ at only one amino-acid residue [15]; this unusually
strong sequence conservation itself suggests that SDF-1
has an important physiological function. In line with this
notion, the SDF-1 null mutants died in utero [12], most
likely as a result of defective hematopoiesis. The numbers
of B-cell progenitors were found to be severely decreased
in fetal liver and bone marrow, and although myeloid prog-
enitors populated the fetal liver in normal numbers, they
were markedly decreased in the bone marrow.
In humans, adult and fetal hematopoiesis occur at distinct
sites: the primary site of hematopoiesis during early
embryogenesis is the yolk sac, but by mid-gestation it has
moved to the liver and spleen; the bone marrow is not a
major contributor to blood-cell formation until very late in
fetal development. The fetal hematopoietic stem cells that
populate the liver and the analogous adult cells that popu-
late the bone marrow have different properties, either
intrinsic to the cells themselves or due to differences in
their microenvironments. For example, whereas the prolif-
eration of adult hematopoietic stem cells requires both ery-
thropoietin and a second colony-stimulating factor, such as
IL-3 or stem cell factor (SCF), hematopoietic stem cells in
embryonic bone marrow can be induced to proliferate by
erythropoietin alone [16]. The knockout mice results [12]
suggest that one explanation for some of these differences
may be the formation of a microenvironment that nurtures
the development of hematopoiesis in the bone marrow.
One aspect of this microenvironment that may be critical is
the secretion of SDF-1 by bone marrow stromal cells.
SDF-1 thus appears to have an important role in establish-
ing hematopoiesis in the bone marrow during development,
so identifying its cellular receptor is of prime importance.
Two groups [17,18] have recently reported that the orphan
‘leukocyte-expressed seven-transmembrane-domain recep-
tor’ (LESTR) confers on cells responsiveness to SDF-1 in
Ca2+-flux assays; the receptor has thus been renamed
CXCR4. Furthermore, in a separate study by one of these
groups [19], SDF-1 was shown to stimulate T-cell migration
and actin polymerization in a dose-responsive manner.
CXCR4 is highly expressed in leukocytes, has a marked
sequence similarity to the IL-8 receptor and its gene has a
similar chromosomal localization to the genes encoding
other C-X-C chemokine receptors. Interestingly, this recep-
tor was also recently identified [20] as an important entry
cofactor for T-cell-tropic, but not macrophage-tropic, HIV-1
strains. The CXCR4 ligand, SDF-1, has accordingly been
shown to block cell invasion by T-cell tropic strains of HIV-
1 [17,18], but not by the macrophage-tropic HIV-1 strains
that use CCR5 and perhaps other b-chemokine receptors as
cofactors for invasion [21,22]. Despite these recent findings,
the importance of chemokines and their receptors in leuko-
cyte production and inflammation remains clear, and this
aspect promises to yield valuable insights into the host’s
repertoire of inflammatory and reparative mechanisms, how
they can be subverted by resourceful infectious agents and
the strategies the host may invoke to evade this piracy.
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